The University of Texas MD Anderson Cancer Center PGY1 pharmacy residency prepares its graduates to practice as an independent patient care clinician, pursue a second year post-graduate training in a specialized area of practice and to serve as a preceptor for pharmacy students. MD Anderson is a premier comprehensive cancer center located in the largest medical center in the world. The Division of Pharmacy at MD Anderson strives to be the pharmacy leader in providing patient-centered care, based on excellence and innovation in automated services, patient care, research, and education. The residency program can provide unique experiences that offer comprehensive pharmacotherapeutic patient management to a variety of settings but not limited to the following: Ambulatory Care, Critical Care, Drug Information, Emergency Medicine, Infectious Diseases, Internal Medicine, Investigational Drug Services, Nutrition Support, Oncology and Practice Management.
Applicants must possess a Pharm.D. degree and Texas Pharmacist licensure is required within 90 days of starting the program.
The University of Texas MD Anderson Cancer Center is one of the world’s most respected centers devoted exclusively to cancer patient care, research, education and prevention. It is located in central Houston in the Texas Medical Center. U.S. News & World Report’s "Best Hospitals" survey has ranked MD Anderson as one of the nation’s top two cancer centers every year since the survey began in 1990. The institution has over 710 inpatient beds and sees over 1.4 million outpatient visits per year. The Division of Pharmacy has over 600 employee's including over 350 registered pharmacists.